GlassScriptPhysician profile
Rajesh C Raman
NPI 1437135951
$1,565.24
in general payments reported to CMS, 2019-2025
18 companies · $238 in 2025
The $238 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $106 · 2021: $136 · 2022: $325 · 2023: $284 · 2024: $244 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $281.52 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $227.72 | 2019-2025 | Doc Band |
| Pfizer INC. | $178.94 | 2019-2023 | |
| Kaleo, INC. | $161.67 | 2019-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $160.88 | 2022-2025 | Bexsero, Menveo |
| Neos Therapeutics, LP | $101.36 | 2019-2025 | Cotempla Xr-Odt |
| Seqirus USA INC | $90.62 | 2022-2025 | Flucelvax |
| Tris Pharma INC | $69.31 | 2021-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $56.08 | 2019 | |
| Sanofi Pasteur INC. | $55.09 | 2023-2024 | |
| Ars Pharmaceuticals Operations, INC. | $40.24 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $30.52 | 2024 | Zoryve |
| Shire North American Group INC | $29.10 | 2019 | |
| Aytu Biopharma, INC. | $25.41 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $15.72 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.50 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.29 | 2021 | |
| Adlon Therapeutics L.P. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Raman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.